您当前的位置：

BMS-1

(Synonyms: PD-1/PD-L1 inhibitor 1)

目录号: PL08984 纯度: ≥99%

BMS-1 是 PD-1/PD-L1 蛋白质/蛋白质相互作用的抑制剂，IC50 为 6 到 100 nM。

CAS No. :1675201-83-8

商品编号	规格	价格	会员价
PL08984-5mg	5mg	¥992.00	请登录
PL08984-10mg	10mg	¥1575.00	请登录
PL08984-25mg	25mg	¥3155.00	请登录
PL08984-50mg	50mg	¥4565.00	请登录
PL08984-100mg	100mg	¥6565.00	请登录
PL08984-200mg	200mg	询价	询价
PL08984-500mg	500mg	¥13295.00	请登录
PL08984-10mM*1mLinDMSO	10mM*1mLinDMSO	¥2121.00	请登录
PL08984-1 mL x 10 mM (in DMSO)		¥992.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	BMS-1
中文别名	PD-L1 抑制剂1;(S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸;(2S)-1-[[2,6-二甲氧基-4-[(2-甲基[1,1'-联苯]-3-基)甲氧基]苯基]甲基]-2-哌啶羧酸
英文名称	BMS-1
英文别名	PD-L1 inhibitor 1;PD1-PDL1 inhibitor 1;PD-1;Pd-1/pd-l1 inhibitor 1;BMS-1;(S)-1-(2,6-dimethoxy-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid;pd-1-pd-l1-inhibitor-1;PD-1/PD-L1 inhibitor 1(C1);BDBM50091334;s7911;PD-1/PD-L1 inhibitor 1;PD1-PDL1 inhibitor 1;Sodium ((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide;(2S)-1-[[2,6
Cas No.	1675201-83-8
分子式	C₂₉H₃₃NO₅
分子量	475.58
包装储存	Powder -20°C 3 years；4°C 2 years
详情描述	BMS-1 是 PD-1/PD-L1 蛋白质/蛋白质相互作用的抑制剂，IC50 为 6 到 100 nM。

产品详情	BMS-1 是 PD-1/PD-L1 蛋白质/蛋白质相互作用的抑制剂，IC₅₀ 为 6 到 100 nM。
生物活性	BMS-1 is an inhibitor of the PD-1/PD-L1 protein/protein interaction (IC 50 between 6 and 100 nM).
性状	Solid
IC50 & Target[1][2]	PD1-PDL1
体外研究(In Vitro)	Since PD-1 mediated the exhaustion of natural killer (NK) cell by binding to its ligand PD-L1, BMS-1 (PD-1/PD-L1 inhibitor 1) (1 μM, 3 days) is used to disturb the interaction between PD-1 and PD-L1. Dexamethasone induced increase of PD-1 expression and decrease of cytotoxicity of the co-cultured NK92 cells are reversed by BMS-1. BMS-1, a small-molecule immune checkpoint inhibitor of PD-1/PD-L1, can be used as a therapeutic strategy for tumor immunotherapy. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	BMS-1 (500 μg/mL; 100 μL; i.p.) significantly increases the survival rates of the mVEGF165b group and mVEGF165b + MUC1 group. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: BALB/
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Zhao Y, et al. Depression Promotes Hepatocellular Carcinoma Progression through a Glucocorticoids Mediated Up-Regulation of PD-1 Expression in Tumor infiltrating NK Cells. Carcinogenesis. 2019 Feb 4. [2]. Li K, et al. Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy. J Drug Target. 2019 Mar;27(3):244-256.

溶解度数据	In Vitro: Methanol : 25 mg/mL (52.57 mM; Need ultrasonic)DMSO : 9 mg/mL (18.92 mM; Need ultrasonic and warming)DMF : 5 mg/mL (10.51 mM; Need ultrasonic)

搜索质检报告(COA)

产品使用指南

Data Sheet

[1]. Zhao Y, et al. Depression Promotes Hepatocellular Carcinoma Progression through a Glucocorticoids Mediated Up-Regulation of PD-1 Expression in Tumor infiltrating NK Cells. Carcinogenesis. 2019 Feb 4.
[2]. Li K, et al. Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy. J Drug Target. 2019 Mar;27(3):244-256.

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

BMS-1

相关产品

The molarity calculator equation

The dilution calculator equation